(Q36437652)
Statements
Administration of neutralizing antibodies to interleukin-6 (IL-6) reduces experimental autoimmune encephalomyelitis and is associated with elevated levels of IL-6 bioactivity in central nervous system and circulation (English)
K Gijbels
S Brocke
J S Abrams
1 November 1995
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference